Biotech Archives - Page 742 of 795

1 minute read

‘Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder’ -STAT

August 17, 1:39 PM

https://www.statnews.com/2022/08/17/bluebird-wins-fda-approval-for-gene-therapy-for-beta-thalassemia/?utm_content=bufferba14a&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic

BLUE

1 minute read

CSL Posts Encouraging Data From Garadacimab In Severe Swelling Attacks

By Vandana Singh

August 17, 12:10 PM

CSL (OTC:CSLLY) announced topline Phase 3 results for garadacimab (CSL312) for hereditary angioedema (HAE). HAE is a rare genetic condition that…

CSLLY

2 minute read

Ambrx Announces Abrupt Leadership Change, Discuses Pipeline Review

By Vandana Singh

August 17, 11:20 AM

Kate Hermans has taken over the reins of Ambrx Biopharma Inc (NASDAQ:AMAM) as interim CEO following the abrupt departure of Feng Tian,…

AMAM

1 minute read

As The Only Monkeypox Maker Struggles, This Small Cap Plans To Develop Novel Shot

By Vandana Singh

August 17, 11:11 AM

Blue Water Vaccines Inc (NASDAQ: BWV)

BVNKF

1 minute read

RedHill Shares Gain As European Commission Grants Orphan Drug Status To NTM Infections Candidate

By Ragothaman Srinivasan

August 17, 10:55 AM

The European Commission has granted Orphan Drug Designation to RedHill Biopharma’s (NASDAQ: RDHL) lead asset RHB-204 for the treatment of nontuberculous mycobacteria (NTM) disease.

RDHL

1 minute read

AbbVie Calls Off Early-Stage Trial For I-Mab’s CD47-Targeted Blood Cancer Candidate

By Vandana Singh

August 17, 10:19 AM

I-Mab (NASDAQ:IMAB) disclosed in an SEC filing that AbbVie Inc (NYSE:ABBV) would discontinue the global Phase 1b study of lemzoparlimab combination therapy with…

ABBV

1 minute read

Intercept Settles Ocaliva Litigation With Reddy’s Lab

By Vandana Singh

August 17, 10:16 AM

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) and its subsidiary Intercept Pharma Europe Limited settled patent litigation with Dr. Reddy’s Laboratories Ltd (NYSE:RDY). The litigation concerns…

ICPT

1 minute read

AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report

By Vandana Singh

August 17, 10:11 AM

AstraZeneca Plc (NASDAQ:AZN) has filed suit against former VP and head of investor relations Chris Sheldon as he prepares…

AZN

1 minute read

Why Eargo Stock Is Rising Today

By Adam Eckert

August 17, 9:44 AM

Eargo Inc (NASDAQ: EAR) shares are trading higher Wednesday after the U.S. Food and Drug Administration on Tuesday issued a final rule to improve access to hearing aids.

EAR

1 minute read

Palisade Bio Shares Drop Following Commencement Of Late-Stage Return Of Bowel Study

By Ragothaman Srinivasan

August 17, 9:44 AM

Palisade Bio (NASDAQ: PALI) has dosed first patient in its Phase 3 study evaluating lead asset LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.

PALI